(HealthDay)—Early treatment with an immune-boosting therapy might improve the outlook of young children with an advanced form of cancer, a new small study suggests.
Oct 10, 2019
0
31
An experimental vaccine against respiratory syncytial virus (RSV), one of the leading causes of infectious disease deaths in infants, has shown early promise in a Phase 1 human clinical trial. A team of researchers, including ...
Aug 1, 2019
0
337
Anaphylactic shock, an exacerbated allergic reaction that can prove fatal, is sometimes caused by the use of drugs during surgery. In most of these extreme reactions, evidence can be provided that patients have anti-drug ...
Jul 10, 2019
0
65
The Ebola virus outbreak of 2014 in West Africa caused more than 11,000 deaths. At the time, scientists were working on several experimental vaccines and treatments but none were licensed for use in humans.
Apr 3, 2019
0
2
A novel immunotherapy appears safe for use in patients with a type of blood cancer called non-Hodgkin's lymphoma, according to a phase-1 multicenter clinical trial led by a researcher at the Stanford University School of ...
Oct 31, 2018
0
91
Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this ...
Nov 22, 2017
0
13
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation ...
Sep 13, 2017
0
69
Neuroblastoma tumors shrank, some dramatically, in 80 percent of newly diagnosed, young, high-risk patients enrolled in a Phase II clinical trial that included an experimental monoclonal antibody. The immunotherapy agent ...
Jun 3, 2016
0
4
The immune system appears to hamper an investigational vaccine from inducing antibodies that protect against HIV infection, but there may be ways to overcome this impediment, according to research led by the Duke Human Vaccine ...
May 4, 2016
0
82
One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.
Mar 3, 2016
0
0
